Beta Bionics, Inc. Common Stock (BBNX) — Defensive Interval Ratio

Latest as of December 2025: 2416 days

Beta Bionics, Inc. Common Stock (BBNX) has a Defensive Interval Ratio of 2416 days as of December 2025. Defensive assets of $204.67 Million (cash $-, short-term investments $187.55 Million, receivables $17.12 Million) cover 2416 days of daily cash needs of $84.72K/day. Check Beta Bionics, Inc. Common Stock tangible book value ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

2416 days
Days of operational coverage

Defensive Assets

$204.67 Million
Cash + ST Investments + Receivables

Daily Cash Need

$84.72K
Current Liabilities ÷ 365

Current Liabilities

$30.92 Million
USD

Beta Bionics, Inc. Common Stock Defensive Interval Ratio (2022–2025)

This chart shows how Beta Bionics, Inc. Common Stock's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the ratio stands at 2416 days, meaning defensive assets of $204.67 Million can fund 2416 days of operations without new revenue. Also explore how fast is Beta Bionics, Inc. Common Stock growing its equity to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for Beta Bionics, Inc. Common Stock (2022–2025)

The table below presents the year-by-year Defensive Interval Ratio for Beta Bionics, Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see BBNX market cap overview.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2025 2416 days $204.67 Million $84.72K/day $- $187.55 Million ▲ +946 days
2024 1469 days $85.14 Million $57.94K/day $- $73.14 Million ▼ -1099 days
2023 2568 days $74.63 Million $29.05K/day $- $70.18 Million ▲ +2568 days
2022 0 days $0.00 $24.31K/day $- $0.00
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)